Skip to content
FY'26FY'25FY'24FY'23
Liquidity
Current ratio3.8×+0.9×2.8×+0.8×2.1×-0.3×2.4×+1.7×
Quick ratio2.4×+0.6×1.8×+0.7×-0.3×1.3×+0.9×
Cash ratio+0.7×0.3×+0.1×0.2×-0.3×0.5×+0.5×
Leverage
Debt-to-assets0.7×+0.6×-0.4×0.4×+0.1×0.4×0.0×
Per Share
Book value per share-$0.76-2,076%$0.04-87.6%$0.31+319%-$0.14-105%
Valuation
Market capitalization$196.92M-35.4%$259.18M+46.4%$177.08M-28.7%$248.34M-11.3%
Enterprise value$333.06M+8.3%$262.04M-6.2%$279.46M-14.0%$325.06M-17.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Lifecore Biomedical, Inc.'s profit margins?
Lifecore Biomedical, Inc. (LFCR) runs a 31.3% gross margin and a -14.5% operating margin, with a -30.0% net margin.
Where do Lifecore Biomedical, Inc.'s ratios come from?
Every ratio is computed from Lifecore Biomedical, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.